Wang et al. [14] also found that AHNAK2 is a target gene of HIF1α, which mediates epithelial-mesenchymal transition (EMT) and stem cell characteristics driven by the hypoxia pathway, thereby promoting the progression of ccRCC. The gene discussed is HIF1A; the disease is nonpapillary renal cell carcinoma.